gip and glp-1 receptor agonist Agonists – Peripheral Brain Frontiers | The evolution of
Description
Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases

Conflict of interest FB: NovoNordisk and Boehringer-Ingelheim, advisor/consultant/speaker

[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Weghuber D, Forslund A, Ahlstrm H, Alderborn A, Bergstrm K, Brunner S, Cadamuro J, Ciba I, Dahlbom M, Heu V, Hofmann J, Kristinsson H, Kullberg J, Ladinger A, Lagler FB, Lidstrm M, Manell H, Meirik M, Mrwald K, Roomp K, Schneider R, Viln H, Widhalm K, Zsoldos F, Bergsten P

The researchers analysis found a significant association between GLP-1 use and reduced breast cancer risk

Upper arm is also possible but often requires assistance due to angle limitations

GLP-1 receptor agonists vs
